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Abstract: High-intensity interval training (HIIT) is known to improve performance and skeletal
muscle energy metabolism. However, whether the body’s adaptation to an exhausting short-term HIIT
is reflected in the resting human metabolome has not been examined so far. Therefore, a randomized
controlled intervention study was performed to investigate the effect of a ten-day HIIT on the resting
urinary metabolome of young active men. Fasting spot urine was collected before (−1 day) and after
(+1 day; +4 days) the training intervention and 65 urinary metabolites were identified by liquid
chromatography-mass spectrometry (LC-MS) and nuclear magnetic resonance (NMR) spectroscopy.
Metabolite concentrations were normalized to urinary creatinine and subjected to univariate statistical
analysis. One day after HIIT, no overall change in resting urinary metabolome, except a significant
difference with decreasing means in urinary hypoxanthine concentration, was documented in the
experimental group. As hypoxanthine is related to purine degradation, lower resting urinary
hypoxanthine levels may indicate a training-induced adaptation in purine nucleotide metabolism.
Keywords: metabolomics; urinary metabolome; hypoxanthine; high-intensity interval training; NMR
spectroscopy; LC-MS
1. Introduction
Over the past decade, research interest in HIIT as a time-efficient method for inducing health
benefits has greatly increased [1]. A growing body of evidence supports the potential of HIIT to cause
similar or even superior improvements in skeletal muscle energy metabolism and cardiometabolic
health as compared to moderate-intensity continuous exercise [2,3]. In order to allow physicians and
sports scientists to recommend more specific exercise programs or training strategies, it is crucial
to know more about the cellular mechanisms and metabolic alterations underlying the whole-body
and skeletal muscle adaptation to HIIT. On a molecular level, there is already strong evidence that
higher exercise intensities lead to a stronger expression of peroxisome proliferator-activated receptor
gamma coactivator (PGC)-1α [4,5], which is regarded as a major regulator of mitochondrial biogenesis
in human skeletal muscle [6]. Given the positive effects that seem to be associated with an increase
in muscle PGC-1α (e.g., an increase in skeletal muscle oxidative capacity or a greater reliance on
fat oxidation [7]) the elevated activity of PGC-1α following HIIT underpins the potential of HIIT
to stimulate long-term metabolic changes that promote widespread health benefits [2,8]. However,
until recently, the majority of studies have focused on the investigation of a small number of key
molecules or selected metabolites in order to elucidate metabolic adaptations to HIIT [5,9–11]. Since
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several biochemical pathways are interacting with each other, capturing a broader view of changes in
metabolism is required.
The emerging metabolomics method offers a more comprehensive approach to simultaneously
analyze a wide range of metabolites. Metabolomics facilitates the systematic identification and
quantification of a large number of metabolites, defined as low-molecular weight compounds, by
using analytical techniques like NMR spectroscopy, LC-MS or gas chromatography-mass spectrometry
(GC-MS) [12]. The complete set of endogenous metabolites like sugars, amino acids, amines, alcohols,
steroids or nucleosides as well as metabolites of exogenous origin in a given biological system—e.g.,
biofluids like blood or urine—represent the so-called “metabolome”. It is determined by age and sex [13]
and can be influenced by external factors like nutrition [14] or physical activity [15,16]. Assessing
the metabolome as comprehensively as possible, metabolomics can provide valuable information
on human metabolism and its response to physiological challenges like physical exercise [17]. Thus,
metabolomics contributes to the identification of exercise-responsive biomarkers, which could act
as predictors of exercise-specific changes in metabolism. Metabolomics can also give insight into
exercise-induced alterations in metabolite profiles, which are possibly associated with particular
physiological processes or metabolic pathways.
Until now, a few studies have investigated the HIIT-induced modifications of the human
metabolome by using metabolomics. The majority of studies have analyzed the acute metabolic effects
of a single HIIT or sprint interval session [18–25], documenting higher concentrations of lactate and
pyruvate, which reflect a higher reliance on anaerobic energy production [18,20,21,23–25], and/or
hypoxanthine, which is known to indicate a high rate of adenosine triphosphate (ATP) turnover [18,23,
24]. However, the middle- and long-term effects of HIIT on the metabolome have rarely been examined
so far. The limitations of existing studies are that training interventions were partly restricted to
overweight individuals [26,27] and performed with a moderate frequency [19,26,27]. Furthermore,
metabolic alterations were only investigated in blood by using either NMR [19] or multi-segment
injection-capillary electrophoresis-mass spectrometry (MSI-CE-MS) [26,27]. Nevertheless, these studies
provide first evidence that high-intensity intermittent training is able to induce adaptive metabolic
responses. Amongst others, this was shown by lower levels of lactate and pyruvate in both resting and
post-exercise serum samples [19] or an attenuated exercise-induced increase in plasma hypoxanthine
levels after HIIT training [27], hinting at a lower energetic stress in the trained status.
However, to the best of our knowledge, no other study has investigated to what extent the body’s
adaptation to an extremely demanding HIIT intervention is reflected in the urinary metabolome.
Especially in elite sports, athletes are often confronted with exhausting training protocols consisting
of high-intensity exercise blocks, provoking a higher adaptation in performance and an improved
fatigue resistance [1,28]. Therefore, the purpose of this study was to investigate the effect of a ten-day
high-intensity interval training, which is comparable to a pre-competition preparation phase in a
periodized training schedule, on the resting urinary metabolome of young active men. This is the first
randomized controlled intervention study using a combined NMR- and LC-MS-based metabolomic
approach to assess changes in urinary metabolite profiles, thereby aiming to identify possible biomarkers
for either training overload or training adaptation. The detected urinary metabolites represent a broad
spectrum of organic compounds found in the human urine metabolome [29], ranging from amino acids
to alcohols, keto acids to purine derivatives and methylated amines. Urine as a biological matrix was
chosen as it is easily accessible, stable and under no homeostatic regulation like other biofluids [29,30].
As the urinary metabolome was captured in the resting state—i.e., in the morning before and after the
ten-day HIIT period—this study was particularly suitable to analyze if human metabolism is able to
restore its disturbed homeostasis, which could be documented in response to acute HIIT [18–24] and
can also be assumed due to an exhausting, daily performed HIIT like in this study.
Metabolites 2019, 9, 137 3 of 18
2. Results
Descriptive characteristics of the participants and training protocols are summarized by means
and standard deviations in Table 1. There were no significant differences between the experimental
group (EG) and the control group (CG) with regard to age, anthropometric parameters and physical
fitness at baseline. Parameters used to create individual training protocols are only presented for the
EG. During daily training sessions, subjects of the EG performed eight cycling bursts at an average
intensity of 348 watt (=Pmax) and for a mean duration of 97 s (=60% Tmax), interrupted by a rest period
until heart rate decreased to an average of 124 beats per minute (=65% of HRmax).
Table 1. Descriptive characteristics of participants and training protocols.
Total (n = 18) EG (n = 10) CG (n = 8)
Age (years) 30.2 ± 7.6 30.0 ± 8.0 30.4 ± 8.0
Height (cm) 182 ± 7 181 ± 7 184 ± 7
Weight (kg) 79.7 ± 7.6 77.1 ± 8.3 82.9 ± 5.5
BMI (kg/m2) 24.0 ± 2.2 23.6 ± 1.6 24.6 ± 2.8
VO2max (mL/(kg/min)) 54.1 ± 8.2 53.0 ± 6.1 55.5 ± 10.6
Pmax (W) 351 ± 30 348 ± 31 355 ± 30
HRmax (bpm) 182 ± 11 181 ± 13 185 ± 8
65% HRmax (bpm) - − - 124 ± 5 - − -
Tmax (s) - − - 162 ± 23 - − -
60% Tmax (s) - − - 97 ± 14 - − -
All values in mean ± SD; BMI: body mass index, CG: control group, EG: experimental group, HRmax: maximum
heart rate, Pmax: lowest power output at VO2max, SD: standard deviation, Tmax: time to exhaustion at Pmax, VO2max:
maximal oxygen consumption.
2.1. Training Parameters
Training parameters demonstrate a high intensity of the daily training (see Figure A1). In the
EG, an increase in blood lactate concentration was documented after each training session and the
post-exercise increase in lactate was 14.2 ± 2.7 mmol/L on the first training day and 16.3 ± 2.7 mmol/L
on the last training day. The average training impulse (TRIMP), which is considered as an objective
tool to assess physical effort, increased continuously over the intervention period (from 56.2 ± 13.4
(day 1) to 96.6 ± 30.0 (day 10)). The heart rate zone scaling shows that the majority of the EG performed
in heart rate zones 3–5, which means that they largely exercised at 70–100% of HRmax. The rating of
perceived exertion (RPE), which is a subjective tool to evaluate exercise intensity, was continuously at
a high level in the EG and did not differ between the training days (mean ± SD (day 1–10): 9.6 ± 0.5;
inter-subject mean ± SD: 9.6 ± 0.2, values are scores in the RPE scale). Regarding the values of
the multidimensional questionnaire for subjective well-being (MDBF, German: Mehrdimensionaler
Befindlichkeitsfragebogen), the mean score from the EG immediately decreased after the first training
session and remained lower than pre-training during the whole training intervention. In the CG, no
changes in MDBF values were observed during the study period.
2.2. Urinary Metabolites
A total of 65 urinary metabolites were identified and quantified by NMR spectroscopy and LC-MS,
including creatinine for standardization purposes. Normalization of urinary metabolite concentrations
to urinary creatinine was conducted with creatinine values obtained by NMR. The NMR signal intensity
of creatinine and creatinine concentrations measured with a photometric assay were highly correlated
(Pearson’s correlation, r = 0.99, p < 0.001; see Supplementary Table S1), verifying the validity of the
quantitative NMR data.
Spot urine samples were collected one day before intervention started (Visit 1, V1) as well as one
and four days after intervention (Visit 2, V2 and Visit 3, V3, respectively). The normalized urinary
metabolite concentrations before and after the 10-day high-intensity interval training are presented
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in Table A1, separated for EG and CG, and as boxplots in the Supplementary Figure S1. Boxplots of
top-ranked metabolites are shown in Figure 1.
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(a) Betaine (EG: n = 9, CG: n = 7); (b) Hypoxanthine (EG: n = 10, CG: n = 8); (c) Taurine (EG: n = 10, CG:
n = 7); CG: Control Group, EG: Experimental Group, p: p-value, V1: Visit 1 (day before the training
started), V2: Visit 2 (day after the the last training session), V3: Visit 3 (after four days of recovery);
metabolites were chosen as top-ranked if at least one p-value was lower than 0.01.
Regarding pre-training urinary metabolite concentrations, no statistically significant differences
between the EG and the CG could be documented. At V2, hypoxanthine (p = 0.0210) showed significantly
different urinary concentrations between the EG and the CG, whereas at V3, urinary concentrations of
betaine (p = 0.0055), hypoxanthine (p = 0.0006) and isoleucine (p = 0.0285) significantly differed between
both groups. With respect to metabolite alterations within the EG, three metabolites significantly
changed over ti e. Firstly, urinary hypoxanthine concentration showed a significant difference with
decreasing means between V1 and V2 (p = 0.0270). Secondly, urinary taurine concentration significantly
differed with decreasing means between V1 and V3 (p = 0.0031), as well as urinary asymmetric
dimethylarginine (ADMA) concentration (p = 0.0380). Within the CG, urinary concentration of
hypoxanthine significantly changed with increasing means between V1 and V3 (p = 0.0437) and V2
and V3 (p = 0.0442). Furthermore, urinary concentrations of citrulline (p = 0.0205), N-methylarginine
(p = 0.0134), methylsuccinate (p = 0.0357) and urea (p = 0.0159) showed a significant difference
with increasing means between V1 and V3 while no significant changes in urinary metabolites were
demonstrated between V1 and V2.
3. Discussion
The purpose of this study was to investigate the effect of a ten-day HIIT on the resting urinary
metabolome of young active men, thus analyzing if human metabolism is able to recuperate from
an extremely demanding exercise intervention. The main finding of this study is that no overall
change in resting urinary metabolome was observed in the EG, except for a significant difference
with decreasing means in urinary hypoxanthine concentration between V1 and V2 and a significant
difference with decreasing means in urinary taurine and ADMA concentrations between V1 and V3.
Assuming that acute alterations in urinary metabolite concentrations have occurred in response to
the daily HIIT sessions—as shown by previous studies with similar high-intensity exercise protocols
but with immediate sample taking [18–20,24]—the almost unchanged urinary metabolome indicates
that metabolism was largely able to restore its disturbed homeostasis in the given time frame of
one or four recovery days, respectively. Although urine as a biological matrix has not been widely
used in exercise metabolomics studies, the ability of urine to reflect acute exercise-induced metabolic
changes occurring in muscle was recently demonstrated [18,20,24]. Consequently, the fact that no
longer-lasting, overall metabolic alterations in urine have been documented in our study leads to
the assumption that skeletal muscle metabolism had already regenerated from acute disturbances
Metabolites 2019, 9, 137 5 of 18
due to HIIT intervention. Acute metabolic changes in response to a single HIIT or comparable
sprint interval training session are particularly characterized by elevations in plasma or urinary
lactate [18,20,21,23,31], confirming that a high percentage of the energy required in muscle is provided
by the anaerobic energy system [32]. Furthermore, acute elevations in plasma or urinary hypoxanthine
were detected [18,20,24,31]. The purine derivative hypoxanthine represents the final ATP breakdown
product in muscle and was proposed as a metabolic indicator of exercise-induced energetic stress [33,34].
If during high-intensive exercise the ATP degradation rate in muscle is higher than the ATP resynthesis
rate, accumulated hypoxanthine can be partly reconverted to inosine monophosphate (IMP) by the
purine salvage enzyme hypoxanthine guanine phosphoribosyltransferase (HGPRT), thus contributing
to ATP restoration, or it leaks out to the blood stream where a further degradation to uric acid or a direct
elimination from body via urine occurs [33,35–37]. An elevated urinary elimination of hypoxanthine
and its downstream metabolite, uric acid, are seen as the endpoint of purine metabolism, representing
an indirect marker of the exercise-induced net ATP loss from muscle to plasma [38,39].
However, despite the high intensity of the training protocol used in our study, we did not
observe an increase in urinary hypoxanthine concentration one day after the last training session.
This observation is in line with results of Stathis et al., which showed that urinary hypoxanthine
excretion rate was only significantly elevated in the first 2 h of recovery, whereas 2 to 24 h post-exercise
no increased urinary hypoxanthine concentration was documented any more [38]. As even lower
post-training urinary hypoxanthine levels were demonstrated in our study (see Table A1 and Figure 1b),
the question arises if adaptations in purine metabolism as a response to the exhausting HIIT have
occurred, resulting in a reduced muscular hypoxanthine loss into blood even in resting conditions
and finally leading to a decreased delivery of hypoxanthine to the kidneys and consequently to a
lower hypoxanthine excretion via urine. Actually, this is the first study showing a decrease in resting
urinary hypoxanthine levels after a short-term, but high-intensive interval training. A previous
study focusing on training-induced alterations in purine metabolism observed changes in resting
as well as post-exercise plasma hypoxanthine concentrations in elite athletes during a one-year
training cycle [40,41]. Indeed, it was shown that resting (and post-exercise) plasma hypoxanthine
decreased from the general to the competition phase, along with the increasing contribution of
high-intensity anaerobic training loads, whereas in the detraining phase, resting (and post-exercise)
plasma hypoxanthine concentration rose and returned to high levels [40,41]. According to Zielinski et
al., plasma hypoxanthine concentrations at rest and after standard exercise can be seen as sensitive
metabolic indicators of training status, providing valuable information about either training adaptation
or overtraining [41]. In contrast to this, another study showed that a seven-day intermittent sprint
training on a bicycle ergometer did not change resting urinary hypoxanthine concentration in active
men [42]. As compared to our study, subjects were untrained and performed a slightly shorter and less
intensive training intervention, which could explain the discrepant results. However, several studies
documented an attenuated exercise-induced accumulation of plasma or urinary hypoxanthine when an
acute maximal activity was performed after repeated high-intensity training compared to pre-training,
suggesting a decrease in muscular purine nucleotide loss due to an improved balance between the
rates of ATP degradation and its resynthesis [27,42–46]. Hellsten-Westing et al. demonstrated that
the attenuation in hypoxanthine eﬄux after a six-week HIIT in habitually active men was associated
with a training-induced, elevated activity of the purine salvage enzyme HGPRT in muscle [45]. As
HGPRT catalyzes the reconversion of hypoxanthine to IMP [35], its intensified activity following
HIIT was interpreted as a training-induced adaptation to enhance the conservation of muscle purine
nucleotides [45]. Such an adaptation seems advantageous, because a lower loss of purines results
in a lower reliance on the comparably slow and metabolically expensive replacement of adenine
nucleotides by the purine de novo synthesis pathway [42].
Unfortunately, neither muscular HGPRT nor acute post-exercise alterations in hypoxanthine
concentration have been analyzed in the present study. Therefore, it only can be speculated that the
decreased resting urinary hypoxanthine levels are evidence of an increased ability of the body to
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conserve or restore the purine nucleotide pool. A previous study has shown a decrease in resting
muscular adenine nucleotide levels after one week of high-intensity intermittent training [46]. Although
not analyzed in the present study, a depletion of muscular adenine nucleotide content in the course
of the 10-day HIIT is also presumable due to the high intensity and frequency of training. As one
possible metabolic adaptation to the short-term HIIT, an elevated HGPRT activity in skeletal muscle
could be suggested. However, if muscular HGPRT activity actually increased after ten days of HIIT, it
is still questionable to what extent a more efficient salvage in muscle is likely to explain the decrease
in urinary hypoxanthine excretion at rest. Indeed, urinary hypoxanthine levels not only depend on
muscular hypoxanthine release, but also on its uptake by red blood cells [47] or the liver and its
further degradation to uric acid [33,34]. Thus, it cannot be ruled out that an increased hypoxanthine
uptake by other, non-muscle tissues underlay the observed decrease in resting urinary hypoxanthine
concentration. As recently shown, not only HGPRT activity in skeletal muscle but also HGPRT activity
in erythrocytes is exercise- and training-dependent [48–50]. Dudzinska et al. demonstrated that
trained subjects had a significantly higher HGPRT activity in erythrocytes at rest [48], which might
contribute to the reduction of resting plasma as well as urinary hypoxanthine levels by utilizing more
hypoxanthine for IMP formation.
Since resting urinary hypoxanthine concentration in the EG was still lower at V3 than pre-training
and not significantly different from V2 (see Table A1 and Figure 1b), the possibility exists that the
performed training induced an increase in purine salvage efficiency, however it is still unclear in
which tissues this adaptation occurred. Providing detailed information about underlying molecular
mechanisms of adaptation to HIIT is out of the scope of this study. It is obvious that subjects of the
EG were exposed to a remarkable metabolic and psychological stress, as indicated by an increase in
post-exercise blood lactate and a decrease in MDBF scores during intervention, which reflect subjective
well-being [51]. Nevertheless, adaptations to the exhaustive HIIT intervention were also demonstrated.
The TRIMP as a marker of training load continuously increased over the 10-day intervention period
in the EG (see Figure A1b), showing that participants were able to realize a higher physical effort in
the course of the intervention. Regarding this and the fact that urinary hypoxanthine levels in the EG
significantly changed post-training, being significantly different from urinary hypoxanthine levels
in the CG at V2 and V3, alterations in purine metabolism could provide one possible mechanism
of the body’s adaptation to HIIT training. Unfortunately, we are not able to explain the significant
differences with increasing means in urinary hypoxanthine levels in the CG between V1 and V3 and
V2 and V3, respectively. It is obvious that the CG showed a higher variation in urinary hypoxanthine
concentrations at V3 when compared with V1 and V2 (see Table A1 and Figure 1b). We assume that
the documented differences are due to a natural variation, which could not be controlled in our study.
The biological relevance of the change in resting urinary taurine levels between V1 and V3 in
the EG (see Table A1 and Figure 1c) has also to be interpreted with caution, since it is known that
the urinary excretion of this semi-essential amino acid varies along with dietary taurine intake [52].
Although urine samples were collected after an overnight fast and after the intake of a standardized
evening meal, it cannot be excluded that participants consumed different amounts of taurine-containing
food like meat, fish, shellfish or energy drinks [52,53] in the days before urine collection. However,
regarding the decrease in urinary taurine within the EG, it could be hypothesized that more taurine
was utilized during HIIT intervention. Taurine is highly concentrated in the muscles [54] and involved
in cell volume regulation, calcium homeostasis, membrane stabilization and antioxidant activities [52],
all important with respect to physical exercise. In a previous study, it was postulated that taurine is
released by contracting muscles during exercise due to osmoregulatory processes, thus leading to an
acute increase in plasma taurine and, when individuals were sufficiently hydrated, a higher urinary
taurine clearance [55]. As taurine cannot be metabolized by humans, it is either excreted via urine
or faeces [52]. To our knowledge, there is a lack of studies investigating the effect of HIIT on taurine
metabolism. Another previous study analyzed the effect of endurance exercise on urinary taurine
excretion. They showed that urinary taurine immediately increased post-exercise, whereas after 24 h,
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the urinary taurine excretion declined to slightly lower levels than baseline [56]. Assuming that in our
study muscular taurine also was acutely released during HIIT intervention, it can be speculated that
the lower urinary taurine levels at V3 might be a result of “restoring” the pre-exercise muscular taurine
content. Since the reabsorption of taurine in the kidneys is variable, ranging from 40% to 99% [57], the
possibility exists that in the regeneration phase more taurine was retained in the body, being reflected
in a lower urinary taurine excretion. Unfortunately, physiological processes underlying the changes in
urinary taurine in the EG remain to be elucidated.
Similar to urinary taurine levels, we documented a decrease in urinary levels of ADMA between
V1 and V3 in the EG. ADMA is endogenously produced from the turnover of arginine-methylated
proteins [58] and can either be metabolized to citrulline and dimethylamine or excreted via urine [58].
As ADMA functions as an inhibitor of nitric oxide synthase, high plasma ADMA levels are considered
as a cardiovascular risk factor [59] and an increased urinary excretion seems to be one of the main
mechanisms lowering ADMA plasma levels [60]. Recently, it was shown that physical exercise
decreases ADMA levels in plasma [61]. However, the effect of exercise on urinary ADMA excretion
in healthy individuals has rarely been examined so far. Despite the statistically significant change in
urinary ADMA between V1 and V3 in our study, the absolute difference was marginal (see Table A1
and Supplementary Figure S1). Regarding this and the fact that we did not observe a significant
difference between V1 and V2 within the EG, we assume that the change in urinary ADMA levels has
no biological relevance with respect to HIIT intervention.
The significant differences with increasing means in urinary concentrations of citrulline,
N-methylarginine, methylsuccinate and urea between V1 and V3 within the CG can hardly be
explained and might be due to uncontrolled variation. For example, the documented increase in
urinary urea levels could likely be an effect of diet—i.e., of an increased protein intake—as urea
represents the terminal product of protein catabolism, being eliminated in urine [62].
Equally, we hypothesize that the difference between groups in urinary levels of isoleucine at V3
can be seen as an evidence of natural variation in the CG, leading to a higher isoleucine excretion
at V3 when compared with the EG. Differences between groups in urinary betaine concentration
at V3 could also be due to uncontrolled variation in the CG. However, as betaine functions as an
organic osmolyte and methyl donor [63], its importance for exercise performance has recently been
discussed [64]. With regard to this and the fact that we could observe a slight, but not significant
increase of urinary betaine levels in the CG (see Figure 1a), it can be speculated that the CG, which had
to refrain from their usual daily training during the study period, demonstrated a minor use of betaine
for exercise-related physiological processes, thus leading to a higher urinary betaine excretion in the
inactive state. However, as the urinary betaine levels already differed slightly at V1 between both
groups, it could be also suggested that diet might account for the higher urinary betaine excretion in the
CG. Differences in urinary betaine might be explained by a different dietary intake of betaine-containing
food like wheat, shellfish or spinach [65,66].
A clear limitation of the present study is that the participants of the CG were instructed to refrain
from heavy exercise, however, their actual physical activity behavior was not recorded. Similarly,
the daily diet of study participants was not controlled. This has to be taken into account when
interpreting the results, as it is known that the urinary excretion of some metabolites can be affected by
diet. Another limitation of our study is that we conducted a targeted metabolomic approach, which
was limited to a specific number of known compounds, and the lack of a comparative metabolomic
analysis in blood, which would have been of great interest in order to facilitate the interpretation of
documented metabolite alterations. Furthermore, as the present study was a follow up investigation
of a study focusing on an univariate and less varying endpoint, there is a lack of statistical power
regarding the analyses of urinary metabolites which show a comparatively higher biological variance.
Therefore, the obtained results need to be evaluated cautiously and can only be interpreted for each
single metabolite. As expected with respect to the moderate sample size, the observed changes in
the metabolite concentrations are marginal when considering multiple hypotheses, which take all
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metabolites simultaneously into account. Consequently, the present study has to be considered as
a pilot study, providing first hints about the possible effects of HIIT on urinary metabolites. More
studies have to be done to confirm the observed HIIT-induced metabolic changes and to extend the
obtained results to a broader population, i.e., not only to young, trained men but also to untrained
individuals and females. With regard to future studies, it would be appropriate to investigate the
effects of a short-term HIIT not only on resting urinary as well as blood metabolite levels but also on
acute post-exercise metabolic changes in the course of intervention. Thus, a more reliable conclusion
about HIIT-induced adaptations in metabolism could be drawn.
4. Materials and Methods
4.1. Subjects and Study Design
Twenty healthy men volunteered to take part in this study. All participants were regularly active,
competition-experienced and participated in training at least three times a week. Further inclusion
criteria were age between 20 and 50 years and BMI ≤ 30 kg/m2. Participants were excluded if they
used any medication, or if they suffered from musculoskeletal injuries within the preceding twelve
months or from chronic diseases. The study consisted of a randomized, controlled trial in which the
participants were firstly subjected to standardized preliminary tests. Participants were then randomly
assigned to either experimental group (EG) or control group (CG) balanced to their age and training
status. Subjects of the EG took part in a ten-day HIIT intervention whereas subjects of the CG were
told to refrain from heavy exercise during the intervention period. In total, two subjects of the CG
dropped out of the study due to illness or technical measurement errors in blood counts, respectively.
The study was approved by the ethics committee of the State Medical Chamber of Baden-Württemberg,
Stuttgart, Germany (DRKS-ID: DRKS00010841) and was conducted in accordance with the declaration
of Helsinki. Written informed consent was obtained from all participants prior to entering the study.
4.2. Preliminary Testing
Before the onset of the study, participants were subjected to a preliminary examination that
included anthropometric measurements (body weight (in kg), body height (in cm) and length of the
lower limbs (in cm)) and the completion of a medical history form. BMI was calculated by dividing the
body weight (in kg) by the height (in meters) squared.
In order to establish an individual training protocol and as a criteria for the randomization
process, maximal oxygen consumption (VO2max) was measured using an incremental protocol
(see Laursen et al. [67]) on a bicycle ergometer (Excalibur Sport Ergometer, Lode B.V., Groningen,
Netherlands). Briefly, each participant pedaled at a self-selected speed for five minutes, workload was
then augmented to 100 watt and finally increased by 15 watt every 30 s until volitional exhaustion, i.e.,
when a pedal frequency of 60 revolutions per minute (rpm) could no longer be maintained. Respiratory
gas exchange was measured breath-by-breath and heart rate was recorded. The incremental test
was considered valid when the following criteria were fulfilled: (1) an initial linear increase and a
subsequent plateau in oxygen consumption, with an increment of less than 2 mL/(kg/min) between
the two final measurements (despite the increase in workload), (2) the achievement of 90% of the
age-predicted maximum heart rate (HRmax), (3) a respiratory exchange ratio >1.10. Endpoints of the
incremental test were VO2max and maximal power (Pmax), which was defined as the lowest power
output at maximal oxygen consumption.
One day after the incremental test, subjects of the EG performed a sprint cycling test (see Laursen
et al. [67]) in order to determine the duration of individual training protocols. Each participant pedaled
at a self-selected speed for five minutes, before workload was augmented to predetermined Pmax until
exhaustion, i.e., when pedal frequency fell below 60 rpm. Endpoint of this test was Tmax, which was
defined as the time the individuals performed at Pmax. Based on the pre-tests, individual training
protocols were created (Table 2), which consisted of eight sets at the intensity Pmax, a duration of 60%
Metabolites 2019, 9, 137 9 of 18
Tmax and a relative recovery period defined by the time needed until heart rate decreased to 65% of
HRmax measured in the incremental test.
Table 2. Training Protocol.
Sets Intensity Duration Rest
8 Pmax 60% Tmax 65% HRmax
Pmax: lowest power output at VO2max, Tmax: time to exhaustion at Pmax, HRmax: maximum heart rate.
4.3. Experimental Protocol
The training protocol was completed daily for ten days in a row by the subjects of the EG. After a
5-min warm-up at 75 watt, participants performed their individual protocol on a bicycle ergometer
(Excalibur Sport Ergometer, Lode B.V., Groningen, The Netherlands). Pre-training (after warm-up)
and post-training capillary blood was drawn to measure lactate concentrations. To assess individual
physiological and psychological stress and as a control for the training process, several tests were
performed by the EG. During each training session, heart rate was continuously recorded (Polar
RS800CX) to calculate the training impulse (TRIMP), following the instructions from Banister et al. [68].
The TRIMP is an objective tool to assess physical effort, considering the individual heart rate responses
to training and the duration of performed exercise. The TRIMP allows the evaluation of the accumulated
time in different heart rate zones based on <60%, 60–70%, 70–80%, 80–90% and >90% of HRmax, as
suggested by Edwards et al. [69]. Immediately post-training, the rating of perceived exertion (RPE)
was asked, following the instructions from Foster et al. [70]. The RPE represents a subjective but valid
method for quantifying exercise intensity. The RPE scale goes from zero to ten, while ten stands for
maximal exertion [70]. Additionally, the EG as well as the CG daily answered a multidimensional
questionnaire for subjective well-being, following the instructions from Steyer et al. [51]. All participants
were asked to refrain from alcohol, performance enhancing supplements and drugs during the whole
intervention. Besides, they were instructed not to change their eating habits during the study period.
Evening meals the days before urine collection were standardized, insofar that participants were asked
to consume pasta with tomato sauce.
4.4. Urine Sample Collection
Fasting spot urine from all participants was collected into polypropylene collection cups the day
before the training started (Visit 1, V1), the day after the last training session (Visit 2, V2) as well as after
four days of recovery (Visit 3, V3). All samples were taken between 9:00 and 10:00 a.m., centrifuged at
1850× g at 4 ◦C for 10 min, separated into aliquots and stored at −80 ◦C until analysis.
In order to minimize the risk of bias through exercise, V1 was scheduled at least three days after
the pre-tests. Additionally, participants were instructed to refrain from physical exercise 48 h before
urine collection—except participants of the EG at V2.
4.5. Metabolomic Analyses
A combined NMR- and LC-MS-based, targeted metabolomic approach was applied to identify and
quantify a broad range of metabolites, thus making it possible to assess changes in urinary metabolome
following intervention. A short overview of both analytical methods will be given in the next section;
more details are available in the supplement of Rist et al. [13].
4.5.1. NMR
All urine samples were analysed by 1D-1H-NMR spectroscopy, as previously described [13].
Briefly, urine samples were centrifuged, and supernatants mixed with 10% of a buffer containing 1.5 M
KH2PO4, 2 mM NaN3, and 0.58 mM TSP in D2O at pH 7.4. Samples were measured at 300 K on a
Bruker 600 MHz spectrometer (AVANCE II with 1H-BBI room temperature probe (Bruker BioSpin
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GmbH, Rheinstetten, Germany)) equipped with a BACS sample changer. Quality control (QC) samples
were prepared by pooling fasting urine samples from all participants. At least one QC sample was
analysed per 24 study samples. The identification and quantitative analysis of 47 urinary metabolites,
including organic acids, amino acids, amines, sugars, sugar alcohols and others, was carried out
with Chenomx NMR Suite 8.1 (Chenomx, Edmonton, AB, Canada). Imprecision was generally <10%
for most analytes, except for succinate. The original NMR dataset as well as technical precision are
presented in the Supplementary Table S2.
4.5.2. LC-MS
In addition to NMR analysis, a targeted ultra-performance liquid chromatography-tandem mass
spectrometry (UPLC-MS/MS) analysis of methylated amino compounds was conducted using an
Acquity H-Class UPLC coupled to a Xevo TQD triple quadrupole MS (both from Waters, Eschborn,
Germany). The method was originally developed for the analysis of trimethylamine N-oxide (TMAO)
and five related compounds in plasma samples (see [13,71]), but was adapted to urine and extended to 28
analytes in this study. Briefly, urine samples were diluted 25 times with eluent A (1:1 acetonitrile/aqueous
50 mM ammonium formate) and separated by an inverse acetonitrile gradient on a polar HILIC column
(Acquity BEH Amide, 100 × 2.1 mm, 1.7 µm, Waters, Eschborn, Germany). Analytes were detected
by positive ESI and timed MRM. Matrix-matched calibrators and controls (3 levels), dedicated
isotope-labelled internal standards and standard addition were used for quantification. Imprecision
was generally <15% for most analytes and levels, with few exceptions. The original LC-MS dataset as
well as technical precision are presented in the Supplementary Table S3. 13 of the detected metabolites
show concentrations below the lower limit of quantification (LLOQ), which was defined by the
following criteria: Signal to noise ratio 10:1, imprecision and bias <30%. However, all values (including
values below LLOQ) were considered for statistical calculations, since the occurrence of such values is
a property of the population. Although it is known that the single values below the LLOQ are more
inaccurate, such values contain valuable information for the description of the whole sample. The use
of the values below the LLOQ is, with respect to the statistical properties, better than any artificial
replacement. The particular LLOQs as well as the specific number of data below the LLOQ were
indicated in the Supplementary Table S4.
Nine urinary metabolites (β-aminoisobutyrate, betaine, carnitine, creatine, dimethylamine,
N,N-dimethylglycine, histidine, trigonelline and TMAO) were accessible by both NMR and LC-MS.
Analyte concentrations obtained by NMR and LC-MS were compared by linear regression. Results are
presented in the Supplementary Figure S2. In brief, the correlations were strong in all cases with R2
> 0.87. Absolute values did also match closely, reflected by slopes near 1 and small intercepts. The
only exceptions were TMAO and dimethylamine, where significant deviations between LC-MS and
NMR were observed. The reason remains unclear, but is likely related to different standardization
and should be considered when comparing results from studies using different methods. Overall, we
observed a high correlation between NMR and LC-MS data in our study. LC-MS analysis generally
offers a higher sensitivity than NMR [72] and peak assignment and integration in NMR is sometimes
critical and pH-dependent. Therefore, further data handling and statistical analysis for the named
metabolites were carried out with the values obtained by LC-MS.
4.6. Data Handling and Statistical Analysis
Metabolite concentrations were normalized to urinary creatinine, thus controlling for variations
in urine dilution. Urinary creatinine concentrations were obtained through 1H-NMR spectroscopy
and verified by the creatinine concentrations measured using a photometric assay based on the
Jaffe reaction (DetectX® Urinary Creatinine Detection Kit, K002-H5, Arbor Assays, Ann Arbor, MI,
USA). Differences between groups in anthropometric characteristics, fitness parameters and baseline
metabolite concentrations were examined by Welch’s t-test. In order to investigate differences in
urinary concentrations for each metabolite, a mixed effect model with treatment (EG, CG), time (V1,
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V2, V3) and treatment-time interaction as fixed factors were applied. To take account of the repeated
measurements and varying baseline values, the random factors were modelled by a random intercept
and a general correlation structure of the error terms. Tukey type contrasts were tested for by multiple
testing adjusted t-tests. As the applied t-tests were considered robust to deviations from normality
assumption and due to a moderate sample size, parametric statistical analysis was used. No kind
of multivariate statistical analysis for the consideration of all metabolites simultaneously, like false
discovery corrections, were performed due to the moderate sample size. Data are presented as
mean ± standard deviation. The level of statistical significance for all analyses was set at α = 0.05.
Statistical analysis was performed using SAS JMP 11.0.0. (SAS Institute Inc. 2013, Cary, NC, USA) and
the software R version 3.4.2 [73] using packages nlme [74] and lsmeans [75]. Sample size can partly
differ due to missing data, e.g., when technical measurement errors occurred or because measured
values were excluded due to biological implausibility.
5. Conclusions
We investigated the effect of a ten-day HIIT on 65 urinary metabolites in young active men. To our
knowledge, this was the first study using a combined NMR- and LC-MS-based metabolomic approach
to assess changes in resting urinary metabolome, which possibly are related to the body’s adaptation to
a HIIT protocol comparable to pre-competition training schedules. Our findings show that no overall
change in resting urinary metabolome, except a decrease in urinary hypoxanthine concentration, was
caused in the EG one day after the HIIT intervention. This result indicates that metabolism was able to
quickly regenerate from acute metabolic disturbances due to the exhausting HIIT. However, as resting
urinary hypoxanthine levels were lower and significantly different following HIIT, training-induced
adaptations in purine nucleotide metabolism can be suggested. To reveal underlying mechanisms,
further studies are necessary.
Supplementary Materials: The following are available online at http://www.mdpi.com/2218-1989/9/7/137/s1,
Figure S1: Boxplots of urinary metabolite concentrations measured with LC-MS and NMR, Figure S2: Comparison
of LC-MS and NMR metabolite data, Table S1: Comparison of creatinine data obtained by NMR and photometric
assay, Table S2: Original NMR data, Table S3: Original LC-MS data, Table S4: LLOQ of LC-MS data.
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Abbreviations
ADMA asymmetric dimethylarginine
ATP adenosine triphosphate
BMI body mass index
CG control group
EG experimental group
GC-MS gas chromatography-mass spectrometry
HGPRT hypoxanthine-guanine phosphoribosyltransferase
HIIT high-intensity interval training
HRmax maximum heart rate
LC-MS liquid chromatography-mass spectrometry
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LLOQ lower limit of quantification
MDBF Mehrdimensionaler Befindlichkeitsfragebogen (German)
MSI-CE-MS multi-segment injection-capillary electrophoresis-mass spectrometry
NMR nuclear magnetic resonance
p p-value of context-dependent test
PGC-1α peroxisome proliferator-activated receptor gamma coactivator 1-alpha
Pmax maximal power
QC quality control
RPE rating of perceived exertion
rpm revolutions per minute
SDMA symmetric dimethylarginine
TMAO trimethylamine-N-oxide
Tmax time to exhaustion at Pmax
TRIMP training impulse
UPLC-MS/MS ultra-performance liquid chromatography-tandem mass spectrometry
V1 visit 1 (day before the training started)
V2 visit 2 (day after the the last training session)
V3 visit 3 (after four days of recovery);
VO2max maximal oxygen consumption
Appendix A
Metabolites 2019, 8, x  12 of 18 
 
V1 visit 1 (day before the training started) 
V2 visit 2 (day after the the last training session) 
V3 visit 3 (after four days of recovery); 
VO2max maximal oxygen consumption 
Appendix A 
 
Figure A1. Training Parameters (a) Post-exercise increase in blood lactate concentration (mean ± SD); 
(b) Mean and single TRIMP score during training intervention; (c) Heart rate zone scaling (% of time 
spent in each HR zone); (d) RPE score (mean ± SD); HR: heart rate, RPE: rating of perceived exertion, 
SD: standard deviation, TRIMP: Training Impulse. 
Figure A1. Training Parameters (a) Post-exercise increase in blood lactate concentration (mean ± SD);
(b) Mean and single TRIMP score during training intervention; (c) Heart rate zone scaling (% of time
spent in each HR zone); (d) RPE score (mean ± SD); HR: heart rate, RPE: rating of perceived exertion,
SD: standard deviation, TRIMP: Training Impulse.
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Table A1. Normalized urinary metabolite concentrations at V1, V2 and V3 (Experimental Group vs. Control Group).
EG (n = 10) CG (n = 8)
V1 V2 V3 V1 V2 V3
β-Aminoisobutyrate 2, c) 13 ± 16 10 ± 11 10 ± 9 3.2 ± 1.1 2.9 ± 1.7 4.6 ± 3.7
γ-Aminobutyrate 2, c) 0.10 ± 0.04 0.11 ± 0.05 0.10 ± 0.07 0.10 ± 0.07 0.13 ± 0.05 0.09 ± 0.03
γ-Butyrobetaine 2, c) 0.25 ± 0.22 0.14 ± 0.10 0.22 ± 0.14 0.15 ± 0.12 0.18 ± 0.11 0.22 ± 0.12
pi-Methylhistidine 2, c) 42 ± 40 45 ± 40 39 ± 32 19 ± 27 19 ± 26 10 ± 8
τ-Methylhistidine 2, c) 18 ± 3 19 ± 2 18 ± 2 21 ± 7 18 ± 4 18 ± 3
1-Methylnicotinamide 1 3.1 ± 1.1 3.8 ± 1.6 3.9 ± 1.3 5.9 ± 3.9 4.3 ± 2.6 5.7 ± 2.7
2-Hydroxyisobutyrate 1 4.2 ± 0.7 4.2 ± 0.9 4.2 ± 0.8 4.0 ± 1.0 3.8 ± 0.9 4.3 ± 1.2
3-Hydroxyisovalerate 1 3.4 ± 1.0 3.4 ± 1.1 2.9 ± 0.6 2.9 ± 0.6 3.0 ± 0.8 3.5 ± 1.3
3-Indoxylsulfate 1 18 ± 8 21 ± 16 20 ± 11 19 ± 4 20 ± 8 17 ± 6
3-Methylxanthine 1 5.2 ± 3.5 6.4 ± 3.1 6.3 ± 5.4 4.3 ± 2.6 3.6 ± 1.6 5.5 ± 4.3
4-Hydroxyphenylacetate 1 8.7 ± 8.5 8.5 ± 4.0 7.9 ± 5.5 6.2 ± 1.6 6.9 ± 2.6 6.3 ± 2.5
Acetate 1 2.8 ± 1.4 3.2 ± 2.4 2.9 ± 1.9 2.9 ± 1.7 3.5 ± 2.0 3.3 ± 1.0
Acetone 1, e) 1.1 ± 0.5 1.0 ± 0.6 1.0 ± 0.9 1.2 ± 1.0 1.8 ± 2.4 1.5 ± 0.8
ADMA 2, c) 3.7 ± 0.4 †b 3.6 ± 0.5 3.4 ± 0.4 †b 3.8 ± 0.7 3.8 ± 0.6 3.7 ± 0.6
Alanine 1 14 ± 6 15 ± 6 14 ± 6 14 ± 6 16 ± 5 13 ± 5
Anserine 2, c) 0.18 ± 0.18 0.23 ± 0.23 0.13 ± 0.10 0.29 ± 0.59 0.12 ± 0.12 0.06 ± 0.02
Arginine 2, c) 2.1 ± 0.9 1.9 ± 0.5 1.7 ± 0.6 1.8 ± 0.5 2.7 ± 2.7 2.1 ± 0.6
Betaine 2, a) c) 3.9 ± 1.1 4.3 ± 1.8 3.9 ± 1.3 * 6.0 ± 3.0 6.0 ± 1.7 7.0 ± 1.9 *
Betonicine 2, c) 0.64 ± 1.38 0.28 ± 0.34 0.19 ± 0.21 0.09 ± 0.10 0.10 ± 0.15 0.04 ± 0.03
Carnitine 2, c) 12 ± 10 10 ± 9 15 ± 11 10 ± 10 10 ± 6 15 ± 5
Carnosine 2, c) 1.0 ± 0.6 1.3 ± 0.7 1.2 ± 0.5 1.3 ± 0.7 1.4 ± 0.6 1.3 ± 0.7
Choline 2, c) 2.0 ± 1.1 1.9 ± 0.9 1.6 ± 0.5 1.7 ± 0.7 2.3 ± 1.7 1.8 ± 0.3
cis-Aconitate 1 10 ± 2 11 ± 2 11 ± 3 11 ± 4 12 ± 4 13 ± 8
Citrate 1 200 ± 130 200 ± 130 190 ± 100 200 ± 100 200 ± 70 230 ± 70
Citrulline 2, c) 0.7 ± 0.4 0.6 ± 0.3 0.6 ± 0.3 0.5 ± 0.3 †b 1.3 ± 1.8 1.1 ± 0.7 †b
Creatine 2, a) c) 2.6 ± 0.8 2.4 ± 0.6 3.2 ± 2.7 4.1 ± 3.4 4.2 ± 3.2 3.1 ± 1.4
Dimethylamine 2, c) 23 ± 7.8 21 ± 2 20 ± 3 21 ± 2 19 ± 2 22 ± 3
N,N-Dimethylglycine 2, a) c) 2.3 ± 0.8 2.7 ± 1.3 2.2 ± 0.9 2.5 ± 1.1 2.7 ± 0.7 2.8 ± 0.8
Dimethylsulfone 1 4.2 ± 3.6 3.9 ± 2.8 3.9 ± 3.1 3.3 ± 1.4 4.5 ± 4.4 4.3 ± 2.2
Formate 1 11 ± 5 13 ± 9 13 ± 7 13 ± 5 15 ± 9 16 ± 5
Gluconate 1 24 ± 8 26 ± 6 24 ± 5 24 ± 5 23 ± 7 2 ± 7
Glycine 1 80 ± 50 72 ± 40 78 ± 41 60 ± 22 61 ± 16 62 ± 24
Glycolate 1 29 ± 8 31 ± 8 30 ± 11 37 ± 13 34 ± 9 34 ± 8
Metabolites 2019, 9, 137 14 of 18
Table A1. Cont.
EG (n = 10) CG (n = 8)
V1 V2 V3 V1 V2 V3
Guanidoacetate 1 13 ± 4 11 ± 4 11 ± 5 13 ± 5 14 ± 6 13 ± 4
Hippurate 1 140 ± 80 170 ± 110 140 ± 70 250 ± 130 190 ± 80 170 ± 110
Histidine 2, c) 58 ± 22 59 ± 21 55 ± 25 60 ± 28 60 ± 15 57 ± 12
Hypoxanthine 1 7.6 ± 3.3 †a 4.8 ± 1.4 * †a 5.8 ± 2.6 * 8.5 ± 2.7 †b 8.2 ± 2.4 * †c 11.4 ± 3.9 * †b †c
Isoleucine 1 0.72 ± 0.32 0.81 ± 0.22 0.61 ± 0.19 * 0.70 ± 0.20 0.78 ± 0.20 0.95 ± 0.51 *
Lactate 1 3.6 ± 0.8 3.8 ± 1.2 3.8 ± 1.4 3.6 ± 1.1 4.3 ± 1.9 3.7 ± 0.8
Leucine 1 2.0 ± 0.5 2.0 ± 0.4 1.9 ± 0.5 1.9 ± 0.2 2.0 ± 0.6 2.0 ± 0.3
Mannitol 1, c) 8.1 ± 4.8 10.4 ± 4.4 10.5 ± 5.7 5.3 ± 5.1 6.3 ± 2.5 10.2 ± 8.8
Methanol 1 2.9 ± 2.5 4.4 ± 4.2 3.7 ± 4.5 2.6 ± 2.4 4.5 ± 6.1 3.6 ± 2.5
Methylamine 1, b) 2.9 ± 1.6 2.4 ± 1.2 2.3 ± 1.0 2.3 ± 0.8 2.4 ± 0.7 2.2 ± 0.7
N-Methylarginine 2, c) 0.03 ± 0.03 0.02 ± 0.01 0.02 ± 0.02 0.01 ± 0.01 †b 0.04 ± 0.06 0.04 ± 0.03 †b
N-Methylproline 2, a) c) 0.08 ± 0.07 0.20 ± 0.31 0.09 ± 0.04 0.25 ± 0.34 0.15 ± 0.15 0.19 ± 0.16
Methylsuccinate 1 5.4 ± 1.4 6.1 ± 2.3 5.7 ± 1.4 6.1 ± 2.4 †b 6.2 ± 1.1 7.4 ± 3.4 †b
Proline 2, a) c) 0.61 ± 0.28 0.56 ± 0.15 0.53 ± 0.07 0.67 ± 0.46 1.10 ± 1.17 0.91 ± 0.43
Pseudouridine 1 11 ± 1 11 ± 1 11 ± 1 11 ± 1 11 ± 1 11 ± 1
Pyruvate 1 2.2 ± 0.8 2.2 ± 0.7 2.0 ± 0.5 2.0 ± 0.6 2.6 ± 1.3 1.8 ± 0.5
Sarcosine 2, a) c) 0.05 ± 0.02 0.05 ± 0.02 0.06 ± 0.05 0.09 ± 0.06 0.11 ± 0.11 0.07 ± 0.06
SDMA 2, c) 33 ± 4 35 ± 4 33 ± 3 34 ± 2 31 ± 1 33 ± 6
Stachydrine 2, c) 15 ± 19 28 ± 30 17 ± 12 17 ± 16 11 ± 11 12 ± 11
Succinate 1 1.4 ± 0.7 2.1 ± 1.4 2.0 ± 1.1 2.5 ± 1.3 2.3 ± 1.8 2.3 ± 0.8
Tartrate 1, b) d) 1.8 ± 1.4 2.9 ± 3.0 2.1 ± 1.8 1.6 ± 1.1 1.9 ± 1.4 1.3 ± 0.5
Taurine 1, c) 44 ± 28 †b 23 ± 25 18 ± 15 †b 36 ± 32 61 ± 68 56 ± 38
Threonine 1 6.8 ± 2.2 6.8 ± 1.8 7.2 ± 2.9 7.6 ± 2.4 7.6 ± 2.7 7.2 ± 3.4
trans-Aconitate 1 3.2 ± 0.7 3.9 ± 1.4 3.5 ± 0.7 3.1 ± 0.6 2.9 ± 1.7 3.0 ± 0.8
Trigonelline 2, c) 15 ± 15 12 ± 10 14 ± 11 12 ± 8 11 ± 7 11 ± 10
Trimethylamine 2, c) 0.28 ± 0.17 0.25 ± 0.10 0.20 ± 0.07 0.25 ± 0.09 0.31 ± 0.19 0.20 ± 0.06
TMAO 2, c) 56 ± 55 45 ± 28 37 ± 23 36 ± 17 30 ± 12 58 ± 42
Tyrosine 1 7.4 ± 2.6 7.5 ± 2.4 7.1 ± 2.5 8.0 ± 2.7 8.6 ± 3.7 8.1 ± 2.6
Uracil 1 7.2 ± 2.8 6.9 ± 3.7 6.8 ± 3.1 6.0 ± 1.4 5.9 ± 2.5 6.0 ± 1.1
Urea 1 2400 ± 1100 2700 ± 1100 2300 ± 800 2100 ± 500 †b 2600 ± 1400 2900 ± 700 †b
Valine 1 2.3 ± 0.7 2.5 ± 0.6 2.4 ± 0.6 2.6 ± 0.4 2.6 ± 0.4 2.6 ± 0.5
All values in mean ± SD; urinary metabolite concentrations were normalized to urinary creatinine concentration and shown as mmol/mol creatinine; ADMA: asymmetric dimethylarginine,
CG: control group, EG: experimental group, p: p-value, SDMA: symmetric dimethylarginine, TMAO: trimethylamine-N-oxide, V1: Visit 1 (day before the training started), V2: Visit 2 (day
after the last training session), V3: Visit 3 (after four days of recovery); 1 NMR-detected, 2 LC-MS-detected, a) n = 9 for EG, b) n = 9 for EG only at V2, c) n = 7 for CG, d) n = 7 for CG only at
V2, e) n = 7 for CG only at V3; * p ≤ 0.05, significant difference between EG and CG at V2 and V3, respectively; †a p ≤ 0.05, significant difference between V1 and V2 within one group
†b p ≤ 0.05, significant difference between V1 and V3 within one group; †c p ≤ 0.05, significant difference between V2 and V3 within one group.
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